Meelis was Director of AI Engineering at Sharecare Inc. (core team at doc.ai, acquired by Sharecare), where he led teams to deploy cutting edge AI models in production. His team’s focus was on digital biomarkers.
He is an expert on clinical trial innovations and sits on the IEEE committee for decentralized clinical trial design and digital biomarkers, where he led development of the most recent recommendations.
He previously built efficient, fast, scalable and secure software systems at a $4 billion hedge fund.
His PhD in ML was with Andrew Zisserman and Timor Kadir at Oxford University, which led to the development of SpineNet. This work won the 2023 award for AI applications in radiology.
He has worked with founders, and founded, at four startups (Latona Medical, Arthronica, THNK.ai, neurobotX), and as founding engineer at hotg.ai.
LinkedIn: LinkedIn profile
Google Scholar: Google scholar
35 years of leadership in the pharmaceutical industry, including big pharma, specialty pharma, and the pharmaceutical services industry.
Direct experience in virtually all regulatory aspects of pharmaceutical development; analytical methods development and validation; product testing and specifications; technology transfer and scale-up; and drug product manufacturing, packaging, labeling, and distribution.
Provided consultation on a large number of CMC (Chemistry, Manufacturing, and Controls), preclinical and clinical-development and regulatory strategies, spanning manufacturing, analytical, and regulatory activities, from pre-formulation to post-approval. Have worked with international project teams across a number of therapeutic areas. Experience with a full range of dosage forms, including 20 years with injectable drug development. Participated in the submission of 27 New Drug Applications (NDAs) and more than 69 Investigational New Drug Applications (INDs). Experience working with dossiers for submission to EU health authorities, including Marketing Authorization Applications (MAAs) and Investigation Medicinal Product Dossier’s (IMPDs).
Enterprise level security and clinical excellence.
We are building with SOC2, GLP, GCP, ICH guidelines and compliance.
Copyright © 2024 Tehistark - All Rights Reserved.
85 Great Portland Street First Floor, London, W1W 7LT